Jorma Lahtela

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Effect of Lifestyle Intervention on the Occurrence of Metabolic Syndrome and its Components in the Finnish Diabetes Prevention Study

Pirjo Ilanne‐Parikka, Johan G. Eriksson, Jaana Lindström et al. · Diabetes Care · 2008 · 218 citations · Full text

Prevalence of the Metabolic Syndrome and Its Components

Pirjo Ilanne‐Parikka, Johan G. Eriksson, Jaana Lindström et al. · Diabetes Care · 2004 · 198 citations · Full text

Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study

Teemu J. Murtola, Teuvo L.J. Tammela, Jorma Lahtela et al. · Cancer Epidemiology Biomarkers & Prevention · 2007 · 189 citations

Self‐reported non‐severe hypoglycaemic events in Europe

C. G. Östenson, Petronella Geelhoed-Duijvestijn, Jorma Lahtela et al. · Diabetic Medicine · 2013 · 169 citations · Full text